- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Menu
Therapeutic Emicizumab antibody from the original Hemlibra® commercial drug.
Showing all 2 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
|---|---|---|---|---|---|---|---|---|---|---|
Clotting Factor IXa and X |
Bispecific Antibody |
Hemlibra® |
30 mg/mL |
– |
2 mg |
-80°C |
2023.09 |
654,30 € |
||
Clotting Factor IXa and X |
Bispecific Antibody |
Hemlibra® |
30 mg/mL |
– |
2 mg |
-80°C |
2024.08 |
654,30 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany
